- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.09. | Astellas brings its first digital health product to US | ||
| 19.09. | Vanda slams FDA rejection of gastroparesis drug | ||
| 19.09. | Neuralink gets breakthrough tag for sight-restoring implant | ||
| 19.09. | Respiratory biotech Upstream joins Nasdaq IPO surge | ||
| 19.09. | ICER mulls GSK COPD drugs ahead of next Medicare negotiation | ||
| 19.09. | Daiichi Sankyo's Vanflyta gets NICE nod for leukaemia | ||
| 19.09. | Organon makes dermatology play with $1.2bn Dermavant buyout | ||
| 18.09. | PBM strikes back at FTC over drug pricing report | ||
| 18.09. | Noom offers cut-price compounded GLP-1 drug for obesity | ||
| 18.09. | Lilly on alert as new Kisqali approval threatens Verzenio | ||
| 18.09. | After FDA no, MSD/Daiichi post new data with lung cancer ADC | ||
| 18.09. | Tobacco firm PMI divests Vectura at a loss after backlash | ||
| 17.09. | FDA clears sleep apnoea feature for new Apple Watch | ||
| 17.09. | Trial sets up filings for Boehringer IPF drug nerandolimast | ||
| 17.09. | ESMO: Pfizer drug helps cancer patients gain weight | ||
| 16.09. | ESMO: J&J cues up phase 3 for Rybrevant in colorectal cancer | ||
| 16.09. | ESMO: NIAGARA backs Imfinzi in bladder cancer, but will FDA? | ||
| 16.09. | Support app for young cancer patients launches in UK | ||
| 16.09. | AbbVie faulted for misleading ad featuring Serena Williams | ||
| 16.09. | ESMO: Incyte's PD-1 treads new ground in anal cancer | ||
| 13.09. | Syneos Health Communications takes the crown at PM Society Digital Awards | ||
| 13.09. | Lilly ramps up Irish manufacturing investment by $1bn | ||
| 13.09. | Apple AirPods get FDA okay for use as OTC hearing aids | ||
| 13.09. | US puts $25m behind Cellino's cell and tissue printing tech | ||
| 13.09. | Armed with $100m funding, F2G prepares to refile antifungal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
